Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Neuropeptides of the VIP family inhibit glioblastoma cell invasion.
VIP-receptor system inactivated the signaling protein AKT.
»
03/14/14
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
GBM cells are auxotrophic for arginine.
»
06/02/14
The inhibitory role of miR-214 in cervical cancer cells through directly targeting mitochondrial transcription factor A (TFAM).
miR-214 enhanced the susceptibility of Hela and Caski cells to the chemotherapy drug cisplatin.
»
01/06/15
Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
Patients with vascular invasion or human papillomavirus (HPV) infection also had lower miR-145 expression levels.
»
09/16/14
Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.
Cirp deficiency decreased the expression of TNFα, IL23/IL17, Bcl-2, Bcl-xL, and Sox2.
»
09/03/14
Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation.
holo-RBP and its receptor STRA6 are potent oncogenes.
»
09/18/14
Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
5-dAzaC induces DNA demethylation of HSD17B1 promoter.
»
03/11/14
Genetic deletion of AEG-1 prevents hepatocarcinogenesis.
AEG-1 supports an NF-κB-mediated inflammatory state that drives HCC.
»
09/05/14
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
32 miRNAs increase PSA levels.
»
10/08/14
The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant.
Greater resistance to HMGN1-expressing tumors seen.
»
09/09/14
< Prev
Next >